Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Cash from Investing Activities

Acadia Pharmaceutica Cash from Investing Activities Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Acadia Pharmaceutica Cash from Investing Activities for the quarter ending June 06, 2020 was $127m a 92.18% increase of 117m year over year
  • Acadia Pharmaceutica Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-43m a -240.70% increase of 103m year over year
  • Acadia Pharmaceutica Annual Cash from Investing Activities for 2019 was $-166m a 56.89% decrease of -94m from 2018
  • Acadia Pharmaceutica Annual Cash from Investing Activities for 2018 was $-71m a 229.35% decrease of -164m from 2017
  • Acadia Pharmaceutica Annual Cash from Investing Activities for 2017 was $92m a 383.24% increase of 354m from 2016
Other Cash Flow Metrics:
  • Acadia Pharmaceutica Cash Flow from Operations for the quarter ending September 09, 2018 was $-42m a 29.29% decrease of -12m year over year
  • Acadia Pharmaceutica Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-22m a 80.38% decrease of -17m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Cash from Investing Activities Data

06/2020$127m
03/2020$30m
12/2019$-209m
09/2019$10m
06/2019$11m
03/2019$23m
12/2018$-189m
09/2018$32m
06/2018$-4m
03/2018$90m

Annual ACAD Cash from Investing Activities Data

2019$-166m
2018$-71m
2017$92m
2016$-262m
2015$148m
2014$-87m
2013$-126m
2012$-26m
2011$6m
2010$-1m